Huntington’s Disease Biomarker Study
Longitudinal Biospecimen Collection for Mitochondrial Metabolomics in Huntington’s Disease
CONDITION: Huntington’s Disease
The purpose of this study is to identify small molecules that can be measure in the blood and spinal fluid to determine the stage and severity of Huntington’s Disease and whether or not a person has the disease.
Who Can Participate
Participants between the 20 and 80 years of age diagnosed with Huntington’s Disease and do not have any other progressive neurological conditions may be eligible for this study. Participants without any neurological disease may also be eligible to participate.